Skip to content

Effect of Vitamin D3 Supplementation on the severity of Stress Urinary Incontinence (SUI) in premenopausal women

Effect of Vitamin D3 Supplementation on the severity of Stress Urinary Incontinence (SUI) in premenopausal women; A double-blind clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190724044318N2
Enrollment
60
Registered
2021-02-11
Start date
2021-01-20
Completion date
Unknown
Last updated
2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress Urinary Incontinence. Stress incontinence (female) (male)

Interventions

Intervention 1: Intervention group: Vitamin D capsule 5000 units prepared by Dana Pharmaceutical Company should be taken weekly for 12 weeks along with Kegel exercise. Kegel exercise is taught to peop

Sponsors

Kerman University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 49 Years

Inclusion criteria

Inclusion criteria: Age : 40 to 49 years. Serum level of vitamin D3 less than 30 ng/ml Confirmation of the diagnosis of stress urinary incontinence by a physician Having a telephone line to follow up the intervention Having at least literate

Exclusion criteria

Exclusion criteria: Use of participants from treatments other than the recommended treatment Any disorder that prevents the absorption of vitamin D3. Such as inflammatory bowel disease (IBD) . Chronic diabetes Chronic liver or kidney disease Hysterectomy History of neoplasia Urinary-genital system Any neurological disease that affects the urinary system or bowel movements, including multiple sclerosis People who have used estrogen or progesterone in the last 6 months.

Design outcomes

Primary

MeasureTime frame
Stress Urinary Incontinence. Timepoint: Before the intervention and 4th – 8th and 12th weeks of the intervention. Method of measurement: ICIQ-SF standard questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Ali Kamali

Kerman University of Medical Sciences

m_kamali1984@yahoo.com+98 34 3342 5400

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 11, 2026